Found 2 hits in this display Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
Leukotriene A-4 hydrolase
(Homo sapiens (Human)) | BDBM327059
(1-{4-[(2S)-2,3-dihydro-1,4- benzodioxin-2-yl]benz...)Show SMILES OCCNC(=O)C1CCN(Cc2ccc(cc2)[C@H]2COc3ccccc3O2)CC1 |r| Show InChI InChI=1S/C23H28N2O4/c26-14-11-24-23(27)19-9-12-25(13-10-19)15-17-5-7-18(8-6-17)22-16-28-20-3-1-2-4-21(20)29-22/h1-8,19,22,26H,9-16H2,(H,24,27)/t22-/m1/s1 | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| KEGG PC cid PC sid UniChem
| US Patent
| n/a | n/a | 0.220 | n/a | n/a | n/a | n/a | n/a | n/a |
Boehringer Ingelheim International GmbH
US Patent
| Assay Description The compounds of the invention are assessed for the ability to interact with human LTA4 hydrolase in an enzymatic assay that measures the ability of ... |
US Patent US9662339 (2017)
BindingDB Entry DOI: 10.7270/Q2GT5Q8D |
More data for this Ligand-Target Pair | |
Leukotriene A-4 hydrolase
(Homo sapiens (Human)) | BDBM327122
(1-[4-(2,3-dihydro-1,4- benzodioxin-2-yl)benzyl]-N...)Show SMILES OCCNC(=O)C1CCN(Cc2ccc(cc2)C2COc3ccccc3O2)CC1 Show InChI InChI=1S/C23H28N2O4/c26-14-11-24-23(27)19-9-12-25(13-10-19)15-17-5-7-18(8-6-17)22-16-28-20-3-1-2-4-21(20)29-22/h1-8,19,22,26H,9-16H2,(H,24,27) | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| KEGG PC cid PC sid UniChem
| US Patent
| n/a | n/a | 0.75 | n/a | n/a | n/a | n/a | n/a | n/a |
Boehringer Ingelheim International GmbH
US Patent
| Assay Description The compounds of the invention are assessed for the ability to interact with human LTA4 hydrolase in an enzymatic assay that measures the ability of ... |
US Patent US9662339 (2017)
BindingDB Entry DOI: 10.7270/Q2GT5Q8D |
More data for this Ligand-Target Pair | |